55 HolmsethSDehnesYHuangYHFollin-ArbeletVVGrutleNJMylonakouMNet alThe density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS
Key benefits Why people compare it 1 14.9% mean body weight reduction demonstrated in STEP 1 trial (N=1,961) 2 20% reduction in major adverse cardiovascular events in SELECT trial (N=17,604) 3 Significant reduction in appetite and food cravings via hypothalamic POMC/CART activation 4 Improved glycemic control with glucose-dependent insulin secretion potentiation 5 Once-weekly dosing enabled by 165-hour plasma half-life and albumin binding 6 86.4% of STEP 1 participants achieved at least 5% body weight loss 7 Demonstrated NAFLD/NASH improvement with reduction in liver fat content 8 Well-characterized safety profile from over 30,000 participants across STEP and SELECT programs Deep research Semaglutide (chemical name: N-epsilon26-[2-(2-[2-(2-[2-(2-((S)-2-carboxy-3-((1S,2R)-3-carboxy-1-(carboxymethyl-carbamoyl)-propylcarbamoyl)-propionylamino)-ethoxy)-ethoxy)-acetylamino]-ethoxy)-ethoxy)-acetyl]-[Aib8,Arg34]-GLP-1-(7-37)-peptide) is a 39-amino-acid peptide with a molecular weight of 4,113.58 Da
Semaglutide triggers weight loss by slowing stomach emptying and signaling fullness to the brainbut this same mechanism can cause diarrhea in the first 48 weeks of treatment
J Diabetes Complications 2016
For example, inflammation is known to play a role in at least a subset of depressive 238 and psychotic disorders 239
Any questions regarding your own health should be addressed to your own physician
